Loading...
XNAS
TTRX
Market cap360mUSD
Oct 08, Last price  
11.39USD
1D
-5.87%
1Q
20.66%
IPO
23.80%
Name

Turn Therapeutics Inc

Chart & performance

D1W1MN
XNAS:TTRX chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
Net income
-3m
L+80.62%
-2,292,267-1,768,415-3,194,080
CFO
-3m
L+88.27%
-1,377,680-1,361,305-2,562,901

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Key people

Bradley Burnam
Chief Executive Officer, Principal Accounting Officer, Director
Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance · since 2025
Neilesh Ghodadra
Chief Medical Officer, Director · since 2018
Martin Dewhurst
Independent Director · since 2026
Andrew Gengos
Independent Director · since 2020
Independent Director Nominee · since 2024
Kent Kester
Independent Director Nominee · since 2024
IPO date
Oct 08, 2025
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFY
2025‑122024‑122023‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT